1. Introduction
===============

Endocrine pancreatic insufficiency (EPI) secondary to acute pancreatitis (AP) turns to be known recently,^\[[@R1],[@R2]\]^ although the scholars have different opinions on the risk factors of it. In 2013, a research from New Zealand found that recurrent attacks of AP, obesity, hypertriglyceridemia, age above 45 years, family history of DM were the risk factors. However, it showed no obvious influence of the disease severity on the pancreatic endocrine function.^\[[@R3]\]^ In 2015, Hsiu-Nien Shen from Taiwan found out the risk of diabetes increases by twofold after AP. But the risk of diabetes for mild AP was similar to that for all AP patients.^\[[@R4]\]^ Both of the 2 studies showed no correlation between the severity of AP and EPI which many scholars disagree with.^\[[@R5]--[@R7]\]^ As one of the largest sever acute pancreatitis (SAP) treatment centers in China, the patients recovered from AP were included randomly into the follow-up study to verify the role of pancreatic necrosis and organ failure in the new-onset diabetes after AP.

2. Material and methods
=======================

2.1. Patients
-------------

From January to December 2016, this study was undertaken in the SAP treatment center of Nanjing University, which is one of the largest SAP centers in China. Around 276 discharged patients in the outpatients' database were randomly invited to participate in the follow-up study by phone or mail. The written informed consent was obtained from each subject. The study was approved by the ethics committee of the Jinling Hospital, Medical School of Nanjing University.

The exclusion criteria were as follows: patients who suffered recurrent AP; patients with chronic pancreatitis; patients with diagnosed DM before AP episodes; patients suffered from chronic diarrhea before AP; patients with intestinal tuberculosis or Crohn\'s disease; patients with family history of DM; patients with incomplete medical record; and patients who died during hospitalization or after discharge from hospital.

2.2. Assessment methods and data collection
-------------------------------------------

Simplified OGTT^\[[@R8]\]^ was applied to assess the pancreatic endocrine function. The value of fasting plasma glucose (FPG), fasting insulins (FINS), 2-hour postprandial blood glucose (2hPG), HOMA-IR from the test was collected as evaluation indexes. The HOMA-IR that represents the condition of insulin resistance was calculated by the formula of \[HOMA-IR = FPG × FINS/22.5\].^\[[@R9],[@R10]\]^ The symptoms, diet, exercise, medication, etc., were inquired and recorded. The images of pancreas contrast-enhanced CT (CECT) scan during hospitalization time were collected and pancreatic necrosis was judged by Balthazar\'s classification through the CECT images.^\[[@R11]\]^ Other major data of each patients during hospitalization such as APACHE II score,^\[[@R12]\]^ persistent organ failure (AKI and ARDS) were also collected.

2.3. Definition
---------------

Diabetes including impaired glucose tolerance (IGT) was defined using the 1999 World Health Organization criteria. Diabetes was diagnosed by typical diabetes symptoms with any of the following items:1.FPG≥7.0 mmol/L.2.Random blood glucose≥11.1 mmol/L.3.FPG\<7.0 mmol/L and 2hPG\>11.1 mmol/L after a 75-g OGTT.

Diabetes was also diagnosed by any of the following items if without classical diabetes symptom:1.FPG\>7.0 mmol/L for 2 times.2.2hPG≥11.1 mmol/L for 2 times.

IGT was diagnosed by FPG\<7.0 mmol/L and 7.8 mmol/L\<2hPG\<11.1 mmol/L after a 75-g OGTT.

2.4. Statistics analysis
------------------------

Statistical analyses were performed using SPSS 22.0 (IBM Co, Armonk, NY). The continuous outcome variable was analyzed by one-way ANOVA and the categorical variable was analyzed by χ^2^ test between the different groups. Odds ratios (ORs) are expressed with 95% confidence intervals (CIs). The linear trend test was used to analyze the risk of new-onset diabetes base on PN and OF. A *P* value of \< .05 was considered significant.

3. Results
==========

3.1. General information
------------------------

Finally, 256 patients were included and 20 patients were excluded due to meeting the exclusion criteria, change of address, or declining to participate in the study. Among the 20 cases, 14 patients (5.1% in all patients) died during hospitalization or after discharge from hospital due to different reasons, 8 for septic shock, 5 for major bleeding, and 1 died out of hospital for unknown reason. Of the 256 eligible patients, there were 168 males and 88 females with a mean age of 43.86 ± 0.81 years. The shortest time interval from the AP onset to follow-up assessment was 1 month and the longest was 260 months with a mean value of 42.93 ± 4.03 months (median, 30 months). The percent of the patients with the time interval\<3 months, 3 months to 5 years and \>5 years was, respectively, 7.9%, 66.4%, and 25.7%. For the etiology, the percent of biliary, hyperlipemia, alcoholic, and others were, respectively, 57.5%, 34.5%, 2.7%, and 5.3%. For the severity, 54 patients (21.1%) were classified as mild AP (MAP), 42 patients (16.4%) as moderate severe AP (MSAP), and the remaining 160 patients (62.5%) were all diagnosed as severe AP (SAP). A total of 175 (68.4%) patients with organ failure and/or severe pancreatic infection were admitted into the ICU. The detail data were listed in Table [1](#T1){ref-type="table"}.
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General characteristics of the patients.

![](medi-97-e10713-g001)

3.2. Morbidity of EPI
---------------------

Around 154 of 256 patients (60.2%) were diagnosed with new-onset diabetes (include IGT), 102 patients (39.8%) were deemed as normal endocrine function as shown in Figure [1](#F1){ref-type="fig"}.

![Morbidity of endocrine pancreatic insufficiency (EPI). EPI = endocrine pancreatic insufficiency.](medi-97-e10713-g002){#F1}

3.3. Comparison of disease severity and metabolism indexes between group DM and group non-DM
--------------------------------------------------------------------------------------------

APACHE II score and Balthazar score of the patients in group DM were significant higher than group non-DM (*F* = 6.09, *P* = .01; *F* = 10.74, *P* = .001). The value of body mass index (BMI) before AP in the 2 groups showed no significant different (*F* = 0.219, *P* = .64). The value of HOMA-IR at follow-up time in group DM was significant higher than group non-DM (*F* = 13.41, *P* = .000) as listed in Table [2](#T2){ref-type="table"}.

###### 

Comparison of disease severity and metabolism indexes between group DM and group non-DM.
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3.4. Risk of new-onset diabetes based on PN and persistent OF
-------------------------------------------------------------

The ratio of PN in group DM and group non-DM was, respectively, 64.7% and 53.0% (χ^2^ = 3.506, *P* = .06). The morbidity of ARDS and AKI in the 2 groups showed no significant difference, respectively (χ^2^ = 3.136, *P* = .07; χ^2^ = 1.595, *P* = .21). Around 184 (71.7%) patients underwent necrosis debridement by percutaneous catheter drainage (PCD) with or without operative necrosectomy (ON) during admission named group debridement. Around 72 (28.3%) patients conducted neither PCD nor ON named group non-debridement. The patients in group debridement easily developed new onset DM than group non-debridement (χ^2^ = 2.385, *P* = .02) as listed in Table [3](#T3){ref-type="table"}. The morbidity of DM after AP gradually increased from the following 4 groups in order, group non-PN and non-OF, group non-PN and OF, group PN and non-OF and group PN and OF in linear trend test (χ^2^ = 4.587, *P* = .03) as shown in Figure [2](#F2){ref-type="fig"}.

###### 

Comparison of the PN and OF between group DM and group non-DM.
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![Risk of new-onset diabetes after AP based on PN and OF. AP = acute pancreatitis, OF = organ failure, PN = pancreatic necrosis.](medi-97-e10713-g005){#F2}

4. Discussion
=============

The new-onset diabetes after AP was often seen and attracted more attention recently. Our study showed 60.2% patients developed DM after AP episodes including IGT which was higher than that in previous studies.^\[[@R3],[@R4]\]^ Several studies had been published regarding the prevention and treatment of new-onset diabetes after AP, but the risk factors remain controversial.^\[[@R5]--[@R7]\]^ Some researchers considered it was related with recurrent attacks, alcohol intake, sex and age, but no relation with the severity of AP.^\[[@R13],[@R14]\]^ Others suggested that new-onset diabetes after AP was determined majorly by the severity of AP.^\[[@R5],[@R6]\]^

The disease severity of AP mainly depends on the occurrence and extent of PN which reflects the pancreas local circumstance and the organs dysfunction which represents the systemic situation. In our study, we found the ratio of PN in group DM was higher than that in group non-DM (64.7% to 53.0%, χ^2^ = 3.506, *P* = .06, likely attributed to type II error), which indicated the role of PN on the new-onset diabetes after AP. Connor et al^\[[@R15]\]^ reviewed the clinical outcomes of 88 patients who underwent pancreatic necrosectomy and found that 33% patients without prior diabetes mellitus developed endocrine insufficiency. Umapathy et al^\[[@R16]\]^ reported the natural history after acute necrotizing pancreatitis and showed new-onset diabetes, oral pancreatic enzyme replacement therapy and disability were noted in 45%, 25%, and 53%, respectively, in eligible patients. Bavare et al^\[[@R17]\]^ found that necrotizing pancreatitis affects pancreatic exocrine or endocrine function in more than half of the patients in the follow-up study for the patients receiving necrosectomy. Tsiotos et al^\[[@R18]\]^ also found that necrotizing pancreatitis had prominent effects on long-term pancreatic exocrine and endocrine function in half of the patients. In a long-term outcomes observation after AP, Winter Gasparoto et al^\[[@R19]\]^ found that endocrine dysfunction was observed in half of the cases, morphological changes were frequent (62.5%) and more prevalent in those who faced extensive necrosis. Boreham and Ammori^\[[@R20]\]^ found that the development of exocrine insufficiency correlated strongly with the extent of pancreatic necrosis (*r* = −0.754, *P* \< .001), and the severity of EPI (n = 4, *r* = −0.453, *P* = .03) in the prospective evaluation of pancreatic exocrine function in patients with AP. Busse and Ainsworth^\[[@R21]\]^ reported 10 years of experience with transgastric necrosectomy for wall-of necrosis (WON) in AP and found that endocrine and exocrine insufficiency was often seen at follow-up. 18 (45%) patients developed late complications defined as endocrine and/or exocrine malfunction of the pancreas (diabetes (n = 10), exocrine insufficiency (n = 4), both diabetes and exocrine insufficiency (n = 4)). Chandrasekaran et al^\[[@R22]\]^ compared the long term outcomes in patients with SAP managed by operative and non-operative measures and found patients undergoing necrosectomy had higher incidence of endocrine dysfunction (61.9% in surgery and 28.5% in non-operative group \[*P* = .05\]).

Hence, PN could play an important role in developing DM. Extensive PN would lead to the atrophy or absence of the pancreas tissue which could decrease the number of normal islet β cells and the amount of secreted insulin.^\[[@R23]\]^ The phenomenon that patients in the group debridement suffered higher incidence of new onset DM than group non-debridement (χ^2^ = 2.385, *P* = .02) reflected the same facts. It is very similar to the pathogenesis of pancreatogenic diabetes after pancreatectomy.^\[[@R24]--[@R26]\]^ The development of DM after pancreatic resection is quite common, with different types of resections conveying different risks for disease progression. Compare to distal pancreatectomy (DP), central pancreatectomy (CP) had a higher postoperative morbidity rate and a higher incidence of pancreatic fistula, but a lower risk of endocrine insufficiency (RR 0.22, 95% CI 0.14 to 0.35; *P* \< .001).^\[[@R27]\]^ DP places patients at a greater risk for the development of new-onset diabetes.^\[[@R28],[@R29]\]^ Oh et al assessed the patients' glucose metabolism and CT scan 1 year after the pancreaticoduodenectomy (PD) and found that the atrophy of the remaining pancreas increases the risk of pancreatogenic DM after PD.^\[[@R30],[@R31]\]^

On the other hand, as to the complication of persistent OF, there was no significant difference in the morbidity of ARDS or AKI between the 2 groups. But fortunately, we also observed that the morbidity of developing DM after AP gradually increased in the following 4 groups in order, group non-PN and non-OF, group non-PN and OF, group PN and non-OF and group PN and OF (χ^2^ = 4.587, *P* = .03). The role of PN combined with OF on the EPI after AP was therefore verified.

Insulin signaling in the target tissues is mediated by stress kinases such as p38 mitogen-activated protein kinase, c-Jun NH2-terminal kinase, inhibitor of NF-kB kinase complex β (IKKβ), AMP-activated protein kinase, and RNA-activated protein kinase.^\[[@R32],[@R33]\]^ This has been one of the key mechanisms observed in the tissues that are implicated in insulin resistance especially in type 2 diabetes mellitus (T2-DM).^\[[@R34]\]^ In our study, we found that the value of HOMA-IR at follow-up time in group DM was higher than that in group non-DM (2.42 ± 0.21 to 1.44 ± 0.10, *F* = 13.41, *P* = .000). Therefore insulin resistance may play an pivotal role in developing DM. Balzano et al^\[[@R35]\]^ found that T3cDM appeared to be associated with classical risk factors for type 2 diabetes (i.e., age, sex, family history of diabetes, and BMI), and both β-cell dysfunction and insulin resistance appeared relevant determinants. T3cDM is a heterogeneous entity strongly overlapped with type 2 diabetes. However, the value of HOMA-IR in the study is obtained during follow-up phase, not the hospitalization time. We need further studies to confirm that the insulin resistance after AP was caused by the AP itself or the potential metabolism status proneness of T2-DM.

5. Conclusion
=============

Patients with both PN and persistent OF may were at increased risk of developing new-onset diabetes after AP. Insulin resistance could be the pivotal mechanism of the development of diabetes.
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